𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Feasibility of treating mild cognitive impairment withcholinesterase inhibitors

✍ Scribed by John Stirling Meyer; Yansheng Li; Gelin Xu; John Thornby; Munir Chowdhury; Minh Quach

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
44 KB
Volume
17
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy of cognitive rehabilitation in
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors
✍ Luca Rozzini; Daniela Costardi; Barbara Vicini Chilovi; Simone Franzoni; Marco T πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 1 views

## Abstract ## Background Individuals who have Mild Cognitive Impairment (MCI) may be in a transitional stage between aging and Alzheimer's disease (AD). The high rate of conversion from MCI to AD makes early treatment an important clinical issue. Recent evidence suggests that cognitive training i

Conceptualization of mild cognitive impa
Conceptualization of mild cognitive impairment: a review
✍ Heather S. Davis; Kenneth Rockwood πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 81 KB

## Abstract ## Background Several factors have prompted renewed interest in the concept of declines in cognitive function that occur in association with aging, in particular the area between normal cognition and dementia. We review the changing conceptualization of what has come to be known as mil

Treatment of the mild cognitive impairme
Treatment of the mild cognitive impairment (MCI)
✍ HervΓ© Allain; DaniΓ¨le BentuΓ©-Ferrer; Yvette Akwa πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 1 views

## Abstract According to Evidence‐Based‐Medicine, any proposal for the rationale treatment of mild cognitive impairment (MCI) must be based on the results of double‐blind, randomized clinical trials (RCTs). However, since MCI at the present time does not constitute a homogeneous clinical syndrome,

Angiotensin converting enzyme (ACE) inhi
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment
✍ Luca Rozzini; Barbara Vicini Chilovi; Erik Bertoletti; Marta Conti; Ilenia Del R πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

## Abstract ## Background Predictors of progression to dementia in individuals with mild cognitive impairment (MCI) define different groups with higher risks of progression. To date, efforts to differentiate those who will progress to dementia from those who will not have proved inconclusive, and